Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer's Herceptin Biosimilar Moving Forward Amid Rising Competition

02 Dec 2016

• By Sten Stovall

Related Content

Biocon Confident As First Biosimilars Seen Hitting Europe In Early 2018

24 Oct 2016

Pfizer Essential Health Is Staying Put And Has A Focused Strategy For Growth

17 Nov 2016

Pfizer/Hospira's Biosimilar Pipeline: Substantial Overlap, Limited Divestiture So Far

03 Sep 2015

Celltrion's Biosimilar Strategy Includes Simultaneous EMA/FDA Reviews

07 Oct 2016

Keeping Track: Mylan Submits Biosimilar Herceptin; FDA Clears Opdivo For Head And Neck Cancer

11 Nov 2016

Related Companies

Pfizer Inc.

Genentech, Inc.

Roche Holding AG

Hospira, Inc.

Viatris Inc.

Biocon, Ltd.

Celltrion, Inc.

Samsung Bioepis Co., Ltd.

Amgen, Inc.

Allergan plc

Additional Topics

Biosimilars Clinical Trials Commercial Cancer BioPharmaceutical

More from Anticancer

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.